INSIGHTS ON LIQUID DOSE MANUFACTURING
-
![Weiler Engineering Virtual Pharma Expo May 2024]( "Does Blow/Fill/Seal Aseptic Packaging Make Sense for Your Drug?")
Does Blow/Fill/Seal Aseptic Packaging Make Sense for Your Drug?Watch to learn about patent-pending Annex 1 technologies and the versatility of drug products that can be filled with Blow/Fill/Seal systems
-
![GettyImages-1790844511-assay-laboratory-machine-plate]( "Three Key Actions To Minimize Dead Volumes")
Three Key Actions To Minimize Dead VolumesMinimizing liquid dead volume helps labs conserve costly reagents and scarce samples while boosting assay throughput. Learn how advanced liquid level detection technologies are driving efficiency.
-
![Compliance GettyImages-1212446127]( "Compressed Gas Contamination: Guidelines For Control In Aseptic Manufacturing")
Compressed Gas Contamination: Guidelines For Control In Aseptic ManufacturingExplore key guidelines for preserving the purity and quality of compressed gas, with an emphasis on contaminants, monitoring, and preventive maintenance practices.
-
![PMS WFI webinar splash-bucket]( "Quality Assurance In Pharmaceutical Water For Injection (WFI) Systems")
Quality Assurance In Pharmaceutical Water For Injection (WFI) SystemsMaintaining the integrity of Water for Injection (WFI) systems is a non-negotiable priority in pharmaceutical manufacturing. Watch this webinar to refine your contamination control strategies.
-
De-Risking A Novel Valve Component For Use With Standard Syringe Systems3/16/2026
A novel valve provides dual‑chamber functionality within standard syringes, keeping two liquid drugs separated until injection while reducing development risk through advanced modeling.
-
AST Virtual Pharma Expo May 20247/1/2024
View this demonstration of a flexible, modular fill-finish machine featuring a fully integrated HMI and automated processing of nested, custom, and ready-to-use vials, syringes, and cartridges.
-
Maximize Quality Assurance Through Rapid Sterility Testing9/10/2024
This webinar explores mitigating the risk of product loss, and production delays, as well as the critical role rapid sterility testing plays in ensuring the quality and safety of cell therapy products.
-
Ensure Sterility In Small-Batch Drug Production1/9/2026
Automation and sterility are critical for small-batch drug manufacturing. Learn how robotic isolators streamline vial filling, reduce contamination risk, and support advanced therapies with precision.
-
Biofluorescent Particle Counters Are Gaining Momentum4/28/2025
The 2025 BioPhorum report highlights challenges and trends in drug filling operations and how they are advancing towards biofluorescent particle counters. Discover an approach that aligns with industry needs.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
![DecFIll]( "Aseptic Filling Solutions")
Explore aseptic filling line solutions that offer an easy-to-operate system designed to enhance production efficiency and reduce changeover time.
-
![stevanato-dual]( "Dual Chamber Cartridges")
Shelf life stability is one of the key challenges for sensitive drug formulations, which have witnessed continuous growth in the past few years and are projected to grow even further in the future.
-
![Pharmaceutical Filling Systems.jpg]( "R&D Pharmaceutical Filling Systems: Powder And Liquid")
If you are looking for filling systems for different products such as liquids, powder or flow-resistant highly viscous materials, Dec provides a modular concept allowing to meet a variety of packaging that is appropriate in the field of research and development as well as clinical trials. Speed up your go-to-market strategy with innovation and modular thinking.
-
![cell and gene]( "Cell And Gene Therapy Development Aseptic R&D Filling Equipment")
Cell and gene therapies have increased in popularity in recent years, and thanks to their ability to provide one-time treatments these therapies will play a significant role in treating some of the world's most challenging diseases. These drug products treat patients afflicted with genetic disorders and cancers by targeting the source of disease and altering its genetic makeup to eliminate its cause or symptoms. These therapies are expensive and complex and have been proven effective in numerous cases, but they present a challenge in producing them at scale and at a reasonable cost.
-
![West-SBO 2 - GCApp_Instron]( "Freeze Your Device Design With An Integrated, Verified PFA System")
Leverage a pre-verified, integrated syringe platform. Accelerate timelines and reduce costs by eliminating drug-independent testing while streamlining regulatory submissions through one source.
